NDC 71173-3000

BUDDATE REGES INTENSIVE TREATMENT

Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7

BUDDATE REGES INTENSIVE TREATMENT is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Buddate Co Ltd. The primary component is Palmitoyl Tetrapeptide-7; Shea Butter; Palmitoyl Tripeptide-1; Butylene Glycol; Hydrogenated Coconut Oil.

Product ID71173-3000_8223be93-b9a1-01ba-e053-2991aa0acc25
NDC71173-3000
Product TypeHuman Otc Drug
Proprietary NameBUDDATE REGES INTENSIVE TREATMENT
Generic NameButylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2017-01-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameBUDDATE Co Ltd
Substance NamePALMITOYL TETRAPEPTIDE-7; SHEA BUTTER; PALMITOYL TRIPEPTIDE-1; BUTYLENE GLYCOL; HYDROGENATED COCONUT OIL
Active Ingredient Strength0 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 71173-3000-1

70 mL in 1 TUBE (71173-3000-1)
Marketing Start Date2017-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71173-3000-1 [71173300001]

BUDDATE REGES INTENSIVE TREATMENT CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-01-01

Drug Details

Active Ingredients

IngredientStrength
PALMITOYL TETRAPEPTIDE-7.000006 g/100mL

OpenFDA Data

SPL SET ID:46495321-fb14-3479-e054-00144ff88e88
Manufacturer
UNII
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.